DNA Repair Drugs Market Regional Analysis:
North America Market Insights
North America industry is poised to account for largest revenue share of 47.5% by 2035,share owing to the rising burden of cancer and the increasing number of investments in the research and development of DNA repair drugs. For instance, according to the American Cancer Society, in 2024, more than 20 lakh new cancer cases are estimated to be detected in the U.S.
The U.S. DNA repair drugs market is expected to exhibit high growth throughout the forecasted period due to the rising personalized medication trend. Manufacturers in the country are focused on developing therapeutic approaches based on individual genetic profiles that can specifically address genetic mutations and repair mechanisms.
Canada is also an opportunistic for DNA repair drugs market, several research institutions in the country are focused on developing effective solutions. For instance, researchers from Toronto revealed human DNA repair by nuclear metamorphosis. To explore this mechanism over 8,500 cancer patient’s data was analysed by them.
APAC Market Insights
Asia Pacific DNA repair drugs market is expected to increase at a fast pace during the forecast period owing to rapid advancements in healthcare infrastructure. Countries such as India, China, and Japan are spending more on advancing their healthcare facilities and innovation in drug development. The increasing awareness of chronic disorders and treatment solutions is also expected to fuel the sales of DNA repair drugs in the region.
India is emerging as a lucrative DNA repair drugs market for pharma companies owing to positive government support and policies. For instance, according to estimates by the India Brand Equity Foundation, the pharma market in India is anticipated to reach USD 130 billion by 2030. As per the same source, in December 2020, an MoU was signed between the Tata Memorial Centre of India and Vietnam National Cancer Hospital to promote exchanges in the field of healthcare services, training and scientific research, and collaboration in the diagnosis and treatment of cancer patients. Such initiatives are set to fuel the sales of DNA repair drugs in the country.
